Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protein kinase C, beta | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serine:threonine protein kinase 38 | 0.001 | 0.026 | 0.026 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.001 | 0.026 | 0.026 |
Echinococcus granulosus | protein kinase C gamma type | 0.0059 | 0.874 | 0.874 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Echinococcus granulosus | protein kinase c iota type | 0.0018 | 0.152 | 0.152 |
Echinococcus multilocularis | RNA directed DNA polymerase | 0.0048 | 0.6697 | 0.6697 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.001 | 0.026 | 0.5 |
Echinococcus multilocularis | Ribosomal protein S6 kinase beta 2 | 0.001 | 0.026 | 0.026 |
Loa Loa (eye worm) | AGC/RSK/MSK protein kinase | 0.001 | 0.026 | 0.0327 |
Schistosoma mansoni | atypical protein kinase C | 0.0018 | 0.152 | 0.152 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.001 | 0.026 | 0.0327 |
Onchocerca volvulus | 0.0009 | 0 | 0.5 | |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Schistosoma mansoni | serine/threonine kinase | 0.001 | 0.026 | 0.026 |
Echinococcus multilocularis | ribosomal protein s6 kinase beta 1 | 0.001 | 0.026 | 0.026 |
Echinococcus granulosus | Ribosomal protein S6 kinase beta 2 | 0.001 | 0.026 | 0.026 |
Echinococcus granulosus | ribosomal protein S6 kinase alpha 3 | 0.001 | 0.026 | 0.026 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.001 | 0.026 | 0.026 |
Toxoplasma gondii | AGC kinase | 0.001 | 0.026 | 0.5 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0019 | 0.1782 | 0.2239 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.001 | 0.026 | 0.026 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0019 | 0.1782 | 0.1782 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Echinococcus granulosus | ribosomal protein s6 kinase beta 1 | 0.001 | 0.026 | 0.026 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0067 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.001 | 0.026 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Echinococcus multilocularis | telomerase reverse transcriptase subunit | 0.0048 | 0.6697 | 0.6697 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0067 | 1 | 1 |
Echinococcus multilocularis | protein kinase c iota type | 0.0018 | 0.152 | 0.152 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Loa Loa (eye worm) | AGC/NDR protein kinase | 0.001 | 0.026 | 0.0327 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.001 | 0.026 | 0.026 |
Entamoeba histolytica | protein kinase, putative | 0.001 | 0.026 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.001 | 0.026 | 0.026 |
Loa Loa (eye worm) | AGC/PKN protein kinase | 0.001 | 0.026 | 0.0327 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.6697 | 0.8417 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.001 | 0.026 | 0.0327 |
Loa Loa (eye worm) | AGC/RSK/RSK protein kinase | 0.001 | 0.026 | 0.0327 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.7957 | 1 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0019 | 0.1782 | 0.1782 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0067 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Echinococcus multilocularis | ribosomal protein S6 kinase alpha 3 | 0.001 | 0.026 | 0.026 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.001 | 0.026 | 1 |
Echinococcus granulosus | NDR protein kinase | 0.001 | 0.026 | 0.026 |
Brugia malayi | Protein kinase c protein 2 | 0.0057 | 0.8257 | 1 |
Echinococcus granulosus | RNA directed DNA polymerase | 0.0048 | 0.6697 | 0.6697 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0059 | 0.874 | 0.874 |
Schistosoma mansoni | serine/threonine protein kinase | 0.001 | 0.026 | 0.026 |
Loa Loa (eye worm) | AGC/DMPK/GEK protein kinase | 0.001 | 0.026 | 0.0327 |
Schistosoma mansoni | serine/threonine protein kinase | 0.001 | 0.026 | 0.026 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.0049 | 0.6997 | 0.8794 |
Entamoeba histolytica | protein kinase, putative | 0.001 | 0.026 | 0.5 |
Brugia malayi | protein kinase C II. | 0.0019 | 0.1782 | 0.1903 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0019 | 0.1782 | 0.1782 |
Entamoeba histolytica | protein kinase, putative | 0.001 | 0.026 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.026 | 0.0327 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 17.1 nM | BindingDB_Patents: Inhibition Assay. Protein Kinase C beta 2 (PKC beta II) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate peptide (A->S, RFARKGSLRQKNV). This transfer is coupled to the oxidation of p-NADH through the activities of Pyruvate Kinase (PK) and Lactate Dehydrogenase (LDH). (3-NADH conversion to NAD+ is monitored by the decrease in absorbance at 340 nm (e=6.22 cm-1 mM-1) using a Molecular Devices SPECTRA max PLUS spectrophotometer.A typical assay was carried out on a 96-well, clear microtiter plate in a Molecular Devices spectrophotometer for 20 minutes at 30 C. in 0.1 mL of assay buffer containing 50 mM HEPES, pH 7.4, 5 nM PKC, 23 units of pyruvate kinase, 33 units of lactate dehydrogenase, 0.15 mM peptide, 0.1 mM ATP, 1 mM DTT, 4 mM PEP, 8 mM MgCl2, 0.3 mM NADH, 60 mM CaCl2, 10 mg/mL PS, 50 ng/mL PMA, 7.5% DMSO and from about 10,000 nM to 0.169 nM compound inhibitor. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.